SCHEMBL30455617

SCHEMBL30455617

CCCCCCCCCCCCCCCCCCCC(=O)[C@@H](N)CCC(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.57
PPARG P37231 7/20 0.57
PPARD Q03181 7/20 0.57
PPARA Q07869 7/20 0.57
HDAC11 Q96DB2 5/20 0.57
TSHR P16473 4/20 0.57
PTPN1 P18031 3/20 0.57
ALDH1A1 P00352 3/20 0.57
TLR2 O60603 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
FABP4 P15090 2/20 0.57
FFAR1 O14842 2/20 0.57
FFAR4 Q5NUL3 2/20 0.57
KMT2A Q03164 2/20 0.57
SLC22A6 Q4U2R8 1/20 0.57
SLC22A8 Q8TCC7 1/20 0.57
MEN1 O00255 1/20 0.57
ESR1 P03372 1/20 0.57
ALOX15 P16050 1/20 0.57
PDE4A P27815 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6267332 1.00 GPR84 (0.57) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL27622244 1.00 GPR84 (0.57) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL16809346 1.00 GPR84 (0.57) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL31088664 1.00 GPR84 (0.57) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL31088649 1.00 GPR84 (0.57) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL27395527 1.00 GPR84 (0.57) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL16919011 0.92 GRM8 (0.54) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL28283044 0.92 GRM8 (0.54) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL28285474 0.91 PPARG (0.65) PPARGPPARDPPARATSHRPTPN1
SCHEMBL31578553 0.89 ALDH1A1 (0.58) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183310-A1 Polypeptide Compounds and Use Thereof in the Prevention or Treatment of Diabetes or Diabetic Complications SHENZHEN TURIER BIOTECH CO., LTD (CN) 2023-06-15 US claimed
US-20240174728-A1 A USE OF A POLYPEPTIDE COMPOUND IN THE PREPARATION OF DRUGS FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASES AND RELATED INTESTINAL FIBROSIS SHENZHEN TURIER BIOTECH CO., LTD. (CN) 2024-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183310-A1 Polypeptide Compounds and Use Thereof in the Prevention or Treatment of Diabetes or Diabetic Complications IAPP, PNLIP, DPP4 GPR84 873/4885PPARG 392/4885PPARD 455/4885
US-20240174728-A1 A USE OF A POLYPEPTIDE COMPOUND IN THE PREPARATION OF DRUGS FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASES AND RELATED INTESTINAL FIBROSIS VIP, FN1, COL14A1 GPR84 2866/4885PPARG 2177/4885PPARD 3572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.